CDEK
← All trials

NCT06083688

Phase 4Interventional

Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.

View on ClinicalTrials.gov ↗

Timeline

Start date
Oct 31, 2024
Primary completion
Jul 31, 2025
Completion date
Dec 31, 2025
First posted
Oct 16, 2023
Last posted
Oct 16, 2023
Enrollment
1000
Arms / groups
4 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.